Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells

Annals of Oncology

Volumn 19, Issue 3, 2008, Pages 496-500

  Bidard, F C ^a,b   Vincent Salomon, A ^a   Sigal Zafrani, B ^a   Dieras V ^a   Mathiot, C ^a   Mignot, L ^a   Thiery, J P ^a   Sastre Garau, X ^a   Pierga, Jean Yves ^a,c  

^a INSTITUT CURIE   (France)

^b INSERM U612   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bone marrow; Breast cancer; Circulating tumor cells; Metastasis; Micrometastasis

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN; HORMONE RECEPTOR;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MICROMETASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 40149098689     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm507     Document Type: Article

References (29)

1. A.F. Chambers A.C. Groom I.C. MacDonald Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 2002 563 572
2. K. Pantel R.H. Brakenhoff Dissecting the metastatic cascade Nat Rev Cancer 4 2004 448 456
3. S. Braun F.D. Vogl B. Naume A pooled analysis of bone marrow micrometastasis in breast cancer N Engl J Med 353 2005 793 802
4. E. Borgen K. Beiske S. Trachsel Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase J Pathol 185 1998 427 434
5. F.C. Bidard A. Vincent-Salomon S. Gomme Bone marrow micrometastasis are a powerful prognostic factor in stage I to III breast cancer patients 2007 Proceedings of the American Association for Cancer Research Annual Meeting: 14-18 April 2007; Los Angeles, CA. Philadelphia, PA: AACR; 2007. Abstract no. 5460
6. W. Janni S. Gastroph F. Hepp Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma Cancer 88 2000 2252 2259
7. M. Cristofanilli G.T. Budd M.J. Ellis Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 2004 781 791
8. M. Cristofanilli D.F. Hayes G.T. Budd Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer J Clin Oncol 23 2005 1420 1430
9. D.F. Hayes M. Cristofanilli G.T. Budd Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival Clin Cancer Res 12 2006 4218 4224
10. G.T. Budd M. Cristofanilli M.J. Ellis Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer Clin Cancer Res 12 2006 6403 6409
11. J.Y. Pierga C. Bonneton A. Vincent-Salomon Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients Clin Cancer Res 10 2004 1392 1400
12. J.Y. Pierga C. Bonneton H. Magdelenat Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer Br J Cancer 89 2003 539 545
13. A. Vincent-Salomon J.Y. Pierga J. Couturier HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management? Br J Cancer 96 2007 654 659
14. E. Borgen B. Naume J.M. Nesland Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells.The European ISHAGE Working Group for Standardization of Tumor Cell Detection Cytotherapy 1 1999 377 388
15. T. Fehm S. Braun V. Muller A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation Cancer 107 2006 885 892
16. E.L. Kaplan P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
17. D.R. Cox Regression models and life tables (with discussion) J R Stat Soc Ser B 34 1972 187 220
18. G. Wiedswang E. Borgen R. Karesen Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer J Clin Oncol 21 2003 3469 3478
19. S. Riethdorf H. Fritsche V. Muller Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system Clin Cancer Res 13 2007 920 928
20. S. Braun C. Kentenich W. Janni Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients J Clin Oncol 18 2000 80 86
21. W. Janni F. Hepp D. Rjosk The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence Cancer 92 2001 46 53
22. G. Wiedswang E. Borgen R. Karesen Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome Clin Cancer Res 10 2004 5342 5348
23. S. Braun K. Pantel P. Muller Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer N Engl J Med 342 2000 525 533
24. Y. Kang W. He S. Tulley Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway Proc Natl Acad Sci USA 102 2005 13909 13914
25. M. Smid Y. Wang J.G. Klijn Genes associated with breast cancer metastatic to bone J Clin Oncol 24 2006 2261 2267
26. S. Ferlicot A. Vincent-Salomon J. Medioni Wide metastatic spreading in infiltrating lobular carcinoma of the breast Eur J Cancer 40 2004 336 341
27. G. Wiedswang E. Borgen C. Schirmer Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer Int J Cancer 118 2006 2013 2019
28. V. Muller N. Stahmann S. Riethdorf Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity Clin Cancer Res 11 2005 3678 3685
29. K. Pantel C. Alix-Panabieres The clinical significance of circulating tumor cells Nat Clin Pract Oncol 4 2007 62 63